Editorial: El Mundo

• Grifols shareholders suffered a severe financial blow, losing 37.7% of their stakes.
• Gotham fund published a report questioning the financial situation of Grifols.
• Grifols restructured plasma companies and resold them to Scranton, a privately-owned company of its founders based in the Netherlands.
• The symbiosis of Grifols and Scranton, which lack transparency in their financial reporting, is under scrutiny.
• Grifols faces further financial strain from donation drop-off due to the pandemic and the accumulation of excessive debt.
• There is a governance issue as the founding family controls the company without all necessary checks.

Conclusion: Grifols needs to relook its financial structure and practices to enhance its transparency and governance, and thereby, reinstate confidence in its shareholders and financial health of the company.

---